Skip to Content

Press Release

Tiziana Life Sci PLC - Director/PDMR Shareholding

April 25, 2019 at 12:00 PM EDT
RNS Number : 1543X
Tiziana Life Sciences PLC
25 April 2019
 
Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

New York/London, 25 April 2019 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 25 April 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought American Depositary Shares each representing 10 ordinary shares of nominal value 3p each in the capital of the Company, as set out below, following prior consultation with the Takeover Panel in relation to Note 11 to Rule 9.1 of the City Code on Takeovers and Mergers.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.

Details  of PDMR / person closely associated

a)

Name

Gabriele Cerrone/Panetta Partners Limited

2.

Reason for the notification: On market acquisition

a)

Position / status

Executive Chairman

b)

Initial notification /amendment

Initial notification

3.

Details of the issuer

a)

Name

Tiziana Life Sciences plc

b)

LEI

213800CED47HI8PIOB36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted

a)

Description of the financial instrument

ADS representing 10 Ordinary Shares of nominal value 3p each

b)

Identification code of the Financial Instrument

ISIN for Tiziana Life Sciences plc ADS: US88875G1013

c)

Nature of the transaction

Acquisition of ADS representing ordinary shares  

d)

Price(s) and volume(s)


Price: $11,759.40; Volume: 1,668

e)

Aggregated information

-     Aggregated volume

-     Price

 

1,668

$11,759.40

 

 

 

 

f)

Date of the transaction

25 April 2019

g)

Place of the transaction

NASDAQ USA  

 

As a result of this transaction Mr Cerrone's interests in the underlying ordinary shares of the Company increases from 64,187,745 (47.036%) to 64,204,425 (47.048%). Mr Cerrone's interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 524,021 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

 

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

 

 

 

+44 (0)20 7493 2853

Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883

Stockdale Securities (Broker)

Antonio Bossi / Andy Crossley

 

+44 (0)20 7601 6100

 

5220149 v1 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDSRXDBGCU